A swine flu vaccine which was given to hundreds of thousands of children here carried an increased risk of developing the sleep disorder narcolepsy, research suggests Wednesday. Pandemrix, a vaccine used in response to the swine flu pandemic that began in 2009, increased children's risk of narcolepsy - a chronic disorder which causes excessive daytime sleepiness, the research pointed out. For every 55,000 doses delivered around one child developed the condition, health experts said. At the height of the pandemic, between October 2009 and March 2010, more than 850,000 English children aged six months to 16 years were given the vaccine. And the jab was also administered to many more people when supplies of the seasonal flu vaccine diminished - 170,000 people, including children, were given the injection between October 2010 to February 2011. But the health experts cautioned that the many children who received the jab are well and are expected to "remain fine" as symptoms appear to develop a few months after the vaccine is given. The injection has not been in use for almost two years. The research, published in the British Medical Journal, examined 75 children aged between four and 18 who were diagnosed with narcolepsy from January 2008 and who attended sleep centres across England. Meanwhile, researchers from the Health Protection Agency (HPA) found that 11 of these had received the vaccine before their symptoms began. After adjusting for clinical conditions, the authors associated the vaccination with a 14-fold increased risk of narcolepsy. In absolute numbers, this means that one in 52,000 to 57,500 doses are associated with narcolepsy, said the authors. Since 2011, the use of the vaccine in people under the age of 20 across Europe has been restricted following reports of increased cases of the sleep disorder - which is characterised by periods of extreme drowsiness, sudden naps, and paralysis attacks. Narcolepsy, which is thought to affect about 20,000 people in the UK, has a genetic component but this has to be triggered by other factors in order for the condition to appear.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkillerMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor